Latest News and Press Releases
Want to stay updated on the latest news?
-
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K Copenhagen, 26 March 2025 ANNOUNCEMENT no.10/2025 CEMAT...
-
Nasdaq Copenhagen Nikolaj Plads 6 DK-1067 Copenhagen K København, 26. marts 2025 SELSKABSMEDDELELSE nr. 10/2025 ...
-
Terrestrial Energy Inc. (“Terrestrial Energy” or the “Company”) is developing a small modular nuclear plant (the Terrestrial “IMSR plant”) using proprietary Generation IV Integral Molten Salt Reactor...
-
HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (“Prairie,” the “Company,” “we,” or “our”) (Nasdaq: PROP) announced today the pricing of an underwritten public offering of $38.5...
-
HOUSTON, March 24, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (“Prairie,” the “Company,” “we,” or “our”) (Nasdaq: PROP), an independent oil and gas company focused on the acquisition and...
-
CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United...
-
We are investigating the fairness of the sale of OptiNose to Paratek Pharmaceuticals for $9.00 per share in cash plus a CVR.
-
Houston, March 20, 2025 (GLOBE NEWSWIRE) -- The Texas Infrastructure Program (TIP) has successfully secured $196 million in revenue anticipation improvement and refunding bonds for Starwood Land, a...
-
CAMBRIDGE, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (“Akebia”) (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by...
-
Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne muscular dystrophy (DMD) cardiomyopathyBLA granted...